# The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

> **NCT04179656** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Second Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Solid Tumor
- HER2 Gene Mutation
- HER-2 Gene Amplification
- HER-2 Protein Overexpression

## Interventions

- **DRUG:** Pyrotinib

## Key facts

- **NCT ID:** NCT04179656
- **Lead sponsor:** Tianjin Medical University Second Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179656, "The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04179656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*